Artal Group S.A. - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 51 filers reported holding SIGILON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$139,000
-39.3%
276,0000.0%0.01%
-50.0%
Q2 2022$229,000
-43.6%
276,0000.0%0.01%
-29.4%
Q1 2022$406,000
-46.7%
276,0000.0%0.02%
-19.0%
Q4 2021$762,000
-51.1%
276,0000.0%0.02%
-40.0%
Q3 2021$1,559,000
-47.3%
276,0000.0%0.04%
-41.7%
Q2 2021$2,961,000
-52.0%
276,0000.0%0.06%
-45.0%
Q1 2021$6,169,000
-53.5%
276,0000.0%0.11%
-61.8%
Q4 2020$13,256,000276,0000.28%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$58,592,0000.61%
HARBOURVEST PARTNERS LLC 740,740$4,185,0000.39%
Monashee Investment Management LLC 317,460$1,794,0000.33%
SOUNDMARK WEALTH MANAGEMENT, LLC 50,555$286,0000.10%
Artal Group S.A. 276,000$1,559,0000.04%
Choate Investment Advisors 66,666$377,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$8,391,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$2,879,0000.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 229,500$1,297,0000.00%
Woodline Partners LP 34,200$193,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders